These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3707598)

  • 21. Effects of some hypolipidemic drugs and phthalic acid esters on fatty acid binding protein in rat liver.
    Kawashima Y; Nakagawa S; Kozuka H
    J Pharmacobiodyn; 1982 Oct; 5(10):771-9. PubMed ID: 7161705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity.
    Bhuiyan AK; Bartlett K; Sherratt HS; Agius L
    Biochem J; 1988 Jul; 253(2):337-43. PubMed ID: 3178716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity.
    Li Y; Leung LK; Glauert HP; Spear BT
    Carcinogenesis; 1996 Nov; 17(11):2305-9. PubMed ID: 8968042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative and simultaneous effects of simvastatin and ciprofibrate on plasma lipid parameters and upon hepatic drug metabolizing and peroxisome proliferation marker enzymes in the male Wistar rat.
    Charmoillaux M; Goudonnet H; Mercenne F; Mounié J; Truchot RC
    Cell Mol Biol; 1991; 37(8):765-71. PubMed ID: 1807786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of eicosanoid metabolism in carcinogenesis by peroxisome proliferators.
    Glauert HP; Hong JT; Leung LK; Wilson MW
    Ann N Y Acad Sci; 1996 Dec; 804():719-21. PubMed ID: 8993604
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo and in vitro peroxisome proliferation properties of selected clofibrate analogues in the rat. Structure-activity relationships.
    Esbenshade TA; Kamanna VS; Newman HA; Tortorella V; Witiak DT; Feller DR
    Biochem Pharmacol; 1990 Sep; 40(6):1263-74. PubMed ID: 2403380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the hypolipidemic drug bezafibrate on the hepatic mixed function oxidase system of the rat: heterogeneity monooxygenase responses.
    Facino RM; Carini M
    Pharmacol Res Commun; 1981 Oct; 13(9):861-71. PubMed ID: 7335763
    [No Abstract]   [Full Text] [Related]  

  • 28. Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse.
    Chianale J; Vollrath V; Wielandt AM; Amigo L; Rigotti A; Nervi F; Gonzalez S; Andrade L; Pizarro M; Accatino L
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):781-6. PubMed ID: 8615769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the glutathione S-transferase inhibitor, tienilic acid, on biliary excretion of sulphobromophthalein.
    Fehring SI; Ahokas JT
    Chem Biol Interact; 1989; 69(1):23-32. PubMed ID: 2914328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on eicosanoid concentrations in rat liver.
    Wilson MW; Leung LK; Hong JT; Glauert HP
    Adv Exp Med Biol; 1997; 400A():439-45. PubMed ID: 9547588
    [No Abstract]   [Full Text] [Related]  

  • 31. The short- and long-term effects of bezafibrate in the rat.
    Fahimi HD; Reinicke A; Sujatta M; Yokota S; Ozel M; Hartig F; Stegmeier K
    Ann N Y Acad Sci; 1982; 386():111-35. PubMed ID: 6953842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further studies on the involvement of selenium in peroxisome proliferation in rat liver. Comparison of effects with clofibric acid and perfluorooctanoic acid and the pharmacokinetics of [14C]clofibrate.
    Olsson U; Sundberg C; Andersson K; De Pierre JW
    Biochem Pharmacol; 1993 Nov; 46(10):1805-10. PubMed ID: 8250967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective increase in acylation of 1-acylglycerophosphorylcholine in livers of rats and mice by peroxisome proliferators.
    Kawashima Y; Hirose A; Kozuka H
    Biochim Biophys Acta; 1984 Apr; 793(2):232-7. PubMed ID: 6712968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and lipid peroxidation in rats.
    Glauert HP; Srinivasan S; Tatum VL; Chen LC; Saxon DM; Lay LT; Borges T; Baker M; Chen LH; Robertson LW
    Biochem Pharmacol; 1992 Mar; 43(6):1353-9. PubMed ID: 1562286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An in vitro demonstration of peroxisome proliferation and increase in peroxisomal beta-oxidation system mRNAs in cultured rat hepatocytes treated with ciprofibrate.
    Thangada S; Alvares K; Mangino M; Usman MI; Rao MS; Reddy JK
    FEBS Lett; 1989 Jul; 250(2):205-10. PubMed ID: 2753129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of clofibric acid and bezafibrate administration on activities of alkaline phosphatase and other enzymes in livers of rats.
    Walli AK; Seidel D
    Res Exp Med (Berl); 1981; 179(2):153-61. PubMed ID: 7280363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats.
    Tamura H; Iida T; Watanabe T; Suga T
    Carcinogenesis; 1990 Mar; 11(3):445-50. PubMed ID: 2311188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of human liver 3alpha-hydroxysteroid dehydrogenase by clofibrate derivatives.
    Matsuura K; Hara A; Kato M; Deyashiki Y; Miyabe Y; Ishikura S; Sugiyama T; Katagiri Y
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1096-103. PubMed ID: 9618412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the enzymatic activity of ligandin by organogermanium, organolead or organotin compounds and the biliary excretion of sulfobromophthalein by the rat.
    Byington KH; Hansbrough E
    J Pharmacol Exp Ther; 1979 Feb; 208(2):248-53. PubMed ID: 762656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma clearance of sulfobromophthalein and its interaction with hepatic binding proteins in normal and analbuminemic rats: is plasma albumin essential for vectorial transport of organic anions in the liver?
    Inoue M; Okajima K; Nagase S; Morino Y
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7654-8. PubMed ID: 6584879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.